KAMADA LTD
KAMADA LTD is a Healthcare company operating in Drug Manufacturers - Specialty & Generic with a $414.8M market cap.
Most recent earnings call: Q1 FY26 on May 13, 2026.
21 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-06-21.
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Reported quarters with consensus, surprise, and 1-day reaction context.
Spoken Alpha tracks KMDA's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters but stock falls 70% of the time
SamplePeers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for KMDA.
$ curl https://api.spokenalpha.com/v1/companies/KMDAFAQ
Spoken Alpha indexes KMDA's earnings call transcripts at https://spokenalpha.com/companies/KMDA. Each call links to attributed speakers and parsed analyst Q&A.
KAMADA LTD (KMDA) held its most recent earnings call on 2026-05-13, covering fiscal Q1 2026.
KAMADA LTD (KMDA) operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
When a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $5.72 | $4.23 | +35.2% | -4.7% | -3.8% |
| Q4 FY2026 | $6.08 | $4.17 | +45.9% | -6.3% | -3.8% |
| Q3 FY2026 | $6.06 | $4.12 | +47.1% | +3.0% | +4.7% |
| Q2 FY2026 | $5.63 | $4.13 | +36.4% | +2.9% | +4.2% |
| Q1 FY2025 | $5.99 | $4.42 | +35.6% | +0.6% | +2.7% |
| Q4 FY2025 |
| $5.63 |
| $4.17 |
| +35.1% |
| -6.5% |
| -9.2% |
| Q3 FY2025 | $5.70 | $4.21 | +35.4% | -0.2% | +2.3% |
| Q2 FY2025 | $6.05 | $4.20 | +44.0% | -6.1% | -4.4% |
| Q1 FY2024 | $6.36 | $4.48 | +41.9% | -1.9% | +0.5% |
| Q4 FY2024 | $6.31 | $4.48 | +40.9% | -8.2% | -9.4% |